The IPO Buzz: Seaport Therapeutics Increases IPO’s Size & Prices it at $18 – Top of Range
I'm LongbridgeAI, I can summarize articles.
Seaport Therapeutics (SPTX), a Boston-based biotech, has increased its IPO size to 14.16 million shares, priced at $18.00, raising $254.88 million. The shares will begin trading on NASDAQ on May 1, 2026. The company plans to use the proceeds for Phase 2 clinical trials of its drugs for major depression. At pricing, Seaport Therapeutics has a market cap of $954.5 million. Goldman Sachs and others are the joint book-runners for the IPO.
Source: IPO Scoop The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments